Simulations Plus, Inc. (NASDAQ:SLP) has earned a consensus broker rating score of 1.00 (Strong Buy) from the one brokers that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy recommendation.

Analysts have set a 1 year consensus target price of $17.35 for the company and are anticipating that the company will post $0.09 EPS for the current quarter, according to Zacks. Zacks has also given Simulations Plus an industry rank of 165 out of 265 based on the ratings given to related companies.

SLP has been the subject of a number of recent research reports. Zacks Investment Research cut Simulations Plus from a “buy” rating to a “hold” rating in a research report on Wednesday, September 20th. BidaskClub raised Simulations Plus from a “hold” rating to a “buy” rating in a research note on Thursday, October 5th.

In related news, major shareholder Walter S. Woltosz sold 18,500 shares of the firm’s stock in a transaction that occurred on Wednesday, September 27th. The stock was sold at an average price of $15.45, for a total value of $285,825.00. Following the completion of the transaction, the insider now directly owns 5,647,916 shares of the company’s stock, valued at approximately $87,260,302.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders sold a total of 55,500 shares of company stock valued at $880,600 over the last ninety days. 36.93% of the stock is currently owned by company insiders.

Large investors have recently made changes to their positions in the business. The Manufacturers Life Insurance Company grew its holdings in Simulations Plus by 13.8% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 8,923 shares of the technology company’s stock valued at $110,000 after buying an additional 1,085 shares during the last quarter. Rhumbline Advisers acquired a new stake in shares of Simulations Plus during the second quarter worth $126,000. OxFORD Asset Management LLP acquired a new stake in shares of Simulations Plus during the second quarter worth $126,000. New York State Common Retirement Fund acquired a new stake in shares of Simulations Plus during the second quarter worth $143,000. Finally, KCG Holdings Inc. acquired a new stake in shares of Simulations Plus during the first quarter worth $152,000. Hedge funds and other institutional investors own 33.41% of the company’s stock.

Shares of Simulations Plus (NASDAQ:SLP) traded up $0.05 during midday trading on Friday, hitting $15.60. The company had a trading volume of 32,695 shares, compared to its average volume of 32,415. The firm has a market cap of $269.65, a PE ratio of 45.88 and a beta of -0.75. Simulations Plus has a 1 year low of $8.81 and a 1 year high of $17.45.

Simulations Plus (NASDAQ:SLP) last announced its earnings results on Tuesday, November 14th. The technology company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.05 by $0.01. Simulations Plus had a return on equity of 23.95% and a net margin of 23.94%. The firm had revenue of $6.30 million during the quarter, compared to analysts’ expectations of $5.01 million. research analysts predict that Simulations Plus will post 0.4 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Monday, November 20th. Investors of record on Monday, November 13th were paid a $0.06 dividend. This is an increase from Simulations Plus’s previous quarterly dividend of $0.05. This represents a $0.24 annualized dividend and a yield of 1.54%. The ex-dividend date was Friday, November 10th. Simulations Plus’s dividend payout ratio (DPR) is presently 72.73%.

COPYRIGHT VIOLATION WARNING: “Zacks: Simulations Plus, Inc. (SLP) Given Consensus Rating of “Strong Buy” by Analysts” was originally reported by American Banking News and is owned by of American Banking News. If you are accessing this story on another domain, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this story can be viewed at

About Simulations Plus

Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.

Get a free copy of the Zacks research report on Simulations Plus (SLP)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Simulations Plus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus Inc. and related companies with's FREE daily email newsletter.